Skip to content
Screener

Embecta Corp. EMBC Q3 2025 earnings

Reported August 8, 2025 · Before market open

Revenue$295.5MBeat by $29.8M
EPS$1.12Beat by $0.67
Revenue estimate$265.7M
EPS estimate$0.46

Next report

Nov 24, 2026 (in 2 months)
Revenue estimate$269.7M
EPS estimate$0.31

Financials

Q3 2025

Income statement

See full
Revenue$295.5M+8.4%
Gross profit$197.1M+3.7%
Operating income$94.0M+68.2%
Net income$45.5M+210%
EPS (diluted)$0.78+212%

Balance sheet

See full
Cash & equivalents$233.6M-17.1%
Total debt$1.5B-8.2%
Total equity-$669.6M+12.3%
Total assets$1.2B-8.7%

Cash flow

See full
Operating cash flow$81.2M—
CapEx$400.0K-95.9%
Free cash flow$80.8M+785%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$597.28M-17.2%
Enterprise value$1.88B-10.1%
P/E7.1×-3.2×
P/S0.5×-0.1×

Profitability

See full
Gross margin62.8%-3.6pp
Operating margin19.2%+4.3pp
Net margin7.6%+1.4pp
FCF margin12%+10.8pp

Returns & leverage

See full
Current ratio2.5×+0.4×

Segments

By product

See full
Pen Needles$216.9M+7.7%
Syringes$35.1M+10.7%
Safety$34.8M+7.4%
Contract Manufacturing$5.5M+52.8%

By geography

See full
United States$160.2M—

FAQ

When did Embecta Corp. report Q3 2025 earnings?
Embecta Corp. (EMBC) reported Q3 2025 earnings on August 8, 2025 before market open.
What were Embecta Corp.'s Q3 2025 revenue and EPS?
Embecta Corp. reported revenue of $295.5M and eps of $1.12 for Q3 2025.
Did Embecta Corp. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $265.7M by $29.8M. EPS beat the consensus estimate of $0.46 by $0.67.
How did Embecta Corp.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.4% from $272.5M a year earlier and eps grew 51.4% from $0.74.
Where can I find Embecta Corp.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001872789-25-000025) and the 10-Q periodic report (0001872789-25-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.